2 recruiting, 1 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow ssCART-19: new trials by email Literature Review of ssCART-19 trials Research Report on ssCART-19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma ssCART-19 - B Cell Lymphoma | Phase 1 / Phase 2 | Recruiting | Shanghai Tongji Hospital, Tongji University School of Medicine | 50 | 2025-04-22 | 2025-06-05 |
| Clinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma ssCART-19 - B Cell Lymphoma | Phase 1 | Recruiting | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 30 | 2025-01-23 | 2026-05-06 |
| Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration) ssCART-19, Fludarabine, Cyclophosphamide - Relapsed or Refractory Acute Lymphoblastic Leukemia | Phase 2 | Unknown | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 50 | 2024-04-01 | 2024-04-19 |
Lymphoma, B-Cell (2) · Recurrence (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd (2) · Shanghai Tongji Hospital, Tongji University School of Medicine (1)
China (3)
Wenjun Zhang, Doctor (1) · Wenjun Zhang, Ph.D. (1)